During Bioinfect2023 we had the chance to catch up with some of the speakers to ask them about their work. Read their perspectives here: Bionow AlderleyPark BW_SciTech Evotec iiconNW Oppilotech PBDBiotech
Interview conducted by Danielle Ellis, B.Sc.Mar 6 2023 2023 BioInfect ConferenceAlderley Park Conference CentreWednesday 1st February 2023 On Wednesday, the 1st of February, 2023, Bionow hosted the 2023 BioInfect Conference at Alderley Park Conference Center. The aim of the conference was to bring the best brains in science, industry, and patient experience together to confront the current challenges within the field of antimicrobial resistance.
I'm Ed Siegwart. I'm the Director of Microbiology at Oppilotech. Originally, my background was in antimicrobial drug development, working as part of CROs. I joined Oppilotech to help advance their antimicrobial drug development programs. Many people are carriers of TB but show no symptoms. Being able to detect viable mycobacteria in the blood tells clinicians something very important; the patient is unable to control the Tb infection and without treatment it will progress to TB disease.
I've been talking about the iiCON Consortium. It was set up two years ago to get academia working with industry and the NHS to fulfill real needs. It's had some spectacular success over the last two years. We've gone from a standing start, getting those partners working together to helping companies get products through to market. The program now covers a 200 million pound portfolio of activity from drugs to vaccines, diagnostics, and other areas.
When I first started talking to the general population about infection, most of them didn't understand what we were talking about. Now you can talk to anybody from school children to old-age pensioners about infection and infectious diseases. They know about diagnostics, vaccines, and drugs. Our job is really to say this isn't just specific to COVID-19.
Resistance is the underlying problem. You soon get resistance as soon as you bring a drug onto the market, certainly in small molecules. One of the people in the audience from the discussion brought that up nicely by asking, “How can you win the race against the development of the resistance?” You only can do that if you get a portfolio of drugs that stagger along and fill in the gaps. - Pia Thomas, VP for Anti-Infectives at Evotec.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
F3 Bahrain: Marti takes maiden win in 2023 season openerPepe Marti won the first FIAFormula3 race of the year in the Bahrain reversed grid encounter, passing Franco Colapinto after two safety car interruptions for his maiden series victory 🏁 Full report ⬇️
Weiterlesen »
Huge Strictly update as show lines up Loose Women star as first 2023 contestantSTRICTLY bosses want Loose Women star Sophie Morgan to be the show’s first wheelchair-using contestant. The glamorous presenter, 38, is paralysed from the chest down after a car crash at 18. A sour…
Weiterlesen »
Aston Martin hit "aggressive" development targets for 2023 F1 carAston Martin Formula 1 technical director Dan Fallows says the Silverstone team hit the “aggressive targets” it set itself when designing this year’s AM23.
Weiterlesen »
Perez: "Worse" 2023 rear tyre good news for F1 driversRed Bull's Sergio Perez thinks Pirelli's new Formula 1 rear tyres have taken a step backwards this year, but he reckons that could be good news for drivers.
Weiterlesen »
Aston Martin hit “aggressive” development targets for 2023 F1 car🗣️'We set some fairly aggressive targets for ourselves. And we did we did sort of largely hit those.' Aston Martin F1 technical director Dan Fallows says the Silverstone team hit the “aggressive targets” it set itself when designing this year’s AM23 ⬇️
Weiterlesen »
The best disposable cameras in 2023With the best disposable cameras, you've got an easy way into the fun of film photography.
Weiterlesen »